Skip to content

Contemporary Modalities in Treatment of Heart Failure

Contemporary Modalities in Treatment of Heart Failure

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02536443
Acronym
COMMIT-HF
Enrollment
4000
Registered
2015-08-31
Start date
2009-01-31
Completion date
2021-12-31
Last updated
2020-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

heart failure, prognosis, clinical characteristics

Brief summary

The Contemporary Modalities In Treatment of Heart Failure Registry (COMMIT-HF) is an observational study on an all-comer systolic heart failure population hospitalized in a highly specialized cardiovascular center. The aim of the study is to assess the clinical characteristics, treatment modalities and prognosis in this population.

Detailed description

The Contemporary Modalities In Treatment of Heart Failure Registry (COMMIT-HF) is a single-center observational study that is underway in the 3rd Chair and Department of Cardiology of Silesian Center for Heart Diseases in Zabrze, Poland. Data collection is patient-based (not event-based). The main objective of the COMMIT-HF Registry is to clarify the overall clinical characteristics of systolic heart failure patients, their demographics and clinical profile, current management, in-hospital outcomes and long-term follow-up, with regard to the administered treatment. The study population is formed by all-comer patients hospitalized in cardiology wards and intensive cardiac care units with a diagnosis of systolic heart failure. For the purpose of this study heart failure is defined as a set of symptoms resulting from myocardial systolic function impairment, confirmed in resting transthoracic echocardiography with left ventricular ejection fraction (LVEF) ≤35%. Patients with acute coronary syndromes are excluded from the analysis. Complete patient demographics; medical history, complete hospitalization data (diagnostic and therapeutic) and in-hospital results are collected in an electronic form by the attending physician. The patients are under constant follow-up for all cause mortality and major adverse events.

Interventions

None listed

Sponsors

Silesian Centre for Heart Diseases
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* symptom based diagnosis of heart failure * echocardiographically confirmed impaired left ventricular ejection fraction ≤35%.

Exclusion criteria

* acute coronary syndrome on admission * ≥ 18 years old

Design outcomes

Primary

MeasureTime frame
Number of participants with reported deaths from any causeFrom date of inclusion until the date of death from any cause, assessed up to 1 year

Secondary

MeasureTime frame
Number of participants with reported cerebrovascular insultFrom date of inclusion until the date of first event, assessed up to 1 year
Number of participants to undergo mechanical circulatory support implantationFrom date of inclusion until the date implantation, assessed up to 1 year
Number of participants with reported heart-failure related rehospitalizationFrom date of inclusion until the date of first event, assessed up to 1 year
Number of participants with reported myocardial infarctionFrom date of inclusion until the date of first event, assessed up to 1 year
Number of participants to undergo orthotopic heart transplantationFrom date of inclusion until the date transplantation, assessed up to 1 year

Countries

Poland

Contacts

Primary ContactLukasz Pyka, MD
pyka@vp.pl+48502412336

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026